Bragar Eagel & Squire investigates GeneDx Holdings Corp. for potential fraud.

Bragar Eagel & Squire, a nationally recognized stockholder rights law firm, is investigating potential claims against GeneDx Holdings Corp. on behalf of GeneDx stockholders. The investigation concerns whether GeneDx has violated federal securities laws and engaged in other unlawful business practices. Click here to participate in the action.

New York, NY — Rosen Law Firm, a global investor rights law firm, has initiated an investigation into potential securities claims against GeneDx Holdings Corp. (NASDAQ: WGS) on behalf of its shareholders. The investigation centers on allegations that GeneDx may have issued materially misleading business information to the investing public, potentially violating federal securities laws and engaging in other unlawful business practices.

The Rosen Law Firm is encouraging investors who purchased GeneDx securities to participate in the prospective class action. Investors may be entitled to compensation without any out-of-pocket fees or costs through a contingency fee arrangement. The firm is preparing a class action seeking recovery of investor losses. To join the prospective class action, investors can visit [https://rosenlegal.com/submit-form/?case_id=40333](https://rosenlegal.com/submit-form/?case_id=40333) or contact Phillip Kim, Esq., toll-free at 866-767-3653 or email case@rosenlegal.com for more information.

The investigation stems from a report published by Grizzly Research on February 5, 2025, titled "Insiders Attest that GeneDx (Nasdaq: WGS) Is Actively Committing Widespread Fraud." The report alleged that GeneDx's growth is largely an illusion, driven by fraudulent schemes and illegal tactics aimed at exploiting Medicaid and Medicare systems to artificially inflate revenue. On this news, GeneDx's stock fell by 6.7% on February 5, 2025 [1].

Rosen Law Firm is recognized for its expertise in securities class actions and shareholder derivative litigation. The firm has achieved significant settlements, including the largest ever securities class action settlement against a Chinese company. Rosen Law Firm has been ranked in the top 4 by ISS Securities Class Action Services each year since 2013, recovering hundreds of millions of dollars for investors. In 2019 alone, the firm secured over $438 million for investors [2].

Investors are advised to select qualified counsel with a proven track record of success. The Rosen Law Firm encourages investors to be cautious and choose counsel with comparable experience, resources, and meaningful peer recognition.

References:
[1] https://www.prnewswire.com/news-releases/rosen-law-firm-encourages-genedx-holdings-corp-investors-to-inquire-about-securities-class-action-investigation--wgs-302542137.html
[2] https://www.globenewswire.com/news-release/2025/09/01/3142212/673/en/WGS-Investor-News-If-You-Have-Suffered-Losses-in-GeneDx-Holdings-Corp-NASDAQ-WGS-You-Are-Encouraged-to-Contact-The-Rosen-Law-Firm-About-Your-Rights.html